Found: 164
Select item for more details and to access through your institution.
2121. Isavuconazole (ISAV) as Primary Anti-Fungal Prophylaxis (PAP) in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS): An Open-Label, Prospective Study.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S718, doi. 10.1093/ofid/ofz360.1801
- By:
- Publication type:
- Article
Cytogenetic abnormalities in essential thrombocythemia at presentation and transformation.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single-institution experience.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Leukemia-inhibitory factor stimulates breast, kidney and prostate cancer cell proliferation by paracrine and autocrine pathways.
- Published in:
- International Journal of Cancer, 1996, v. 66, n. 4, p. 515, doi. 10.1002/(SICI)1097-0215(19960516)66:4<515::AID-IJC15>3.0.CO;2-6
- By:
- Publication type:
- Article
Clinical and molecular characteristics and treatment patterns of adolescent and young adult patients with chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 1, p. 61, doi. 10.1111/bjh.17498
- By:
- Publication type:
- Article
Association of gene mutations with time‐to‐first treatment in 384 treatment‐naive chronic lymphocytic leukaemia patients.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 3, p. 307, doi. 10.1111/bjh.16042
- By:
- Publication type:
- Article
The landscape of genetic mutations in patients with chronic lymphocytic leukaemia and complex karyotype.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 1, p. e1, doi. 10.1111/bjh.16117
- By:
- Publication type:
- Article
Pentraxin‐3 plasma levels correlate with tumour burden and overall survival in patients with primary myelofibrosis.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 2, p. 382, doi. 10.1111/bjh.15528
- By:
- Publication type:
- Article
Ocular extramedullary myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 5, p. 738, doi. 10.1111/bjh.14430
- By:
- Publication type:
- Article
The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 1, p. 33, doi. 10.1111/bjh.15018
- By:
- Publication type:
- Article
Long-term follow-up of patients receiving allogeneic stem cell transplant for chronic lymphocytic leukaemia: mixed T-cell chimerism is associated with high relapse risk and inferior survival.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 4, p. 567, doi. 10.1111/bjh.14596
- By:
- Publication type:
- Article
Minimal residual disease assessed by multi-parameter flow cytometry is highly prognostic in adult patients with acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 3, p. 392, doi. 10.1111/bjh.13834
- By:
- Publication type:
- Article
The addition of CD20 monoclonal antibodies to lenalidomide improves response rates and survival in relapsed/refractory patients with chronic lymphocytic leukaemia relative to lenalidomide monotherapy - the MD Anderson Cancer Center experience.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 2, p. 281, doi. 10.1111/bjh.13377
- By:
- Publication type:
- Article
Very high levels of lactate dehydrogenase at diagnosis predict central nervous system relapse in acute promyelocytic leukaemia.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 4, p. 595, doi. 10.1111/bjh.13230
- By:
- Publication type:
- Article
Salvage therapy using FLT3 inhibitors may improve long-term outcome of relapsed or refractory AML in patients with FLT3- ITD.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 5, p. 659, doi. 10.1111/bjh.12299
- By:
- Publication type:
- Article
Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells.
- Published in:
- Molecular Cancer, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1476-4598-12-50
- By:
- Publication type:
- Article
Ex vivo expansion of apheresis-derived peripheral blood hematopoietic progenitors.
- Published in:
- Journal of Clinical Apheresis, 2002, v. 17, n. 1, p. 7, doi. 10.1002/jca.10012
- By:
- Publication type:
- Article
TP53‐altered chronic lymphocytic leukemia treated with firstline Bruton's tyrosine kinase inhibitor‐based therapy: A retrospective analysis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 8, p. 1005, doi. 10.1002/ajh.26595
- By:
- Publication type:
- Article
Long‐term results of low‐intensity chemotherapy with clofarabine or cladribine combined with low‐dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. 914, doi. 10.1002/ajh.26206
- By:
- Publication type:
- Article
Clinical outcomes and influence of mutation clonal dominance in oligomonocytic and classical chronic myelomonocytic leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 2, p. E50, doi. 10.1002/ajh.26044
- By:
- Publication type:
- Article
The cXcr4-sTaT3-il-10 Pathway controls the immunoregulatory Function of chronic lymphocytic leukemia and is Modulated by lenalidomide.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2017.01773
- By:
- Publication type:
- Article
The PI3-Kinase Delta Inhibitor Idelalisib (GS-1101) Targets Integrin-Mediated Adhesion of Chronic Lymphocytic Leukemia (CLL) Cell to Endothelial and Marrow Stromal Cells.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0083830
- By:
- Publication type:
- Article
Small Molecule ErbB Inhibitors Decrease Proliferative Signaling and Promote Apoptosis in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0070608
- By:
- Publication type:
- Article
Signal Transducer and Activator of Transcription–3 Induces MicroRNA-155 Expression in Chronic Lymphocytic Leukemia.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0064678
- By:
- Publication type:
- Article
Deletion of TAK1 in the Myeloid Lineage Results in the Spontaneous Development of Myelomonocytic Leukemia in Mice.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0051228
- By:
- Publication type:
- Article
Transformation of Human Mesenchymal Cells and Skin Fibroblasts into Hematopoietic Cells.
- Published in:
- PLoS ONE, 2011, v. 6, n. 6, p. 1, doi. 10.1371/journal.pone.0021250
- By:
- Publication type:
- Article
Stat3 Activates the Receptor Tyrosine Kinase Like Orphan Receptor-1 Gene in Chronic Lymphocytic Leukemia Cells.
- Published in:
- PLoS ONE, 2010, v. 5, n. 7, p. 1, doi. 10.1371/journal.pone.0011859
- By:
- Publication type:
- Article
Association of bone marrow fibrosis with inferior survival outcomes in chronic myelomonocytic leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Patient characteristics and outcomes in adolescents and young adults with classical Philadelphia chromosome-negative myeloproliferative neoplasms.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Mutant FLT3: A Direct Target of Sorafenib in Acute Myelogenous Leukemia.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 3, p. 184, doi. 10.1093/jnci/djm328
- By:
- Publication type:
- Article
OSW-1: a Natural Compound With Potent Anticancer Activity and a Novel Mechanism of Action.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 23, p. 1781, doi. 10.1093/jnci/dji404
- By:
- Publication type:
- Article
Lymphocytic variant of hypereosinophilic syndrome: A report of seven cases from a single institution.
- Published in:
- Cytometry. Part B, 2021, v. 100, n. 3, p. 352, doi. 10.1002/cyto.b.21874
- By:
- Publication type:
- Article
Stem Cells and Somatic Cells: Reprogramming and Plasticity.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, p. S319, doi. 10.3816/CLM.2009.s.031
- By:
- Publication type:
- Article
The synthetic heat shock protein 90 (Hsp90) inhibitor EC141 induces degradation of Bcr-Abl p190 protein and apoptosis of Ph-positive acute lymphoblastic leukemia cells.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 6, p. 1206, doi. 10.1007/s10637-010-9465-8
- By:
- Publication type:
- Article
Preclinical characterization of atiprimod, a novel JAK2 AND JAK3 inhibitor.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 5, p. 818, doi. 10.1007/s10637-010-9429-z
- By:
- Publication type:
- Article
Kit inhibitor APcK110 extends survival in an AML xenograft mouse model.
- Published in:
- 2011
- By:
- Publication type:
- Report
Efficacy and safety of generic imatinib after switching from original imatinib in patients treated for chronic myeloid leukemia in the United States.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 15, p. 6559, doi. 10.1002/cam4.2545
- By:
- Publication type:
- Article
A prospective analysis of symptom burden for patients with chronic myeloid leukemia in chronic phase treated with frontline second‐ and third‐generation tyrosine kinase inhibitors.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 11, p. 5457, doi. 10.1002/cam4.1808
- By:
- Publication type:
- Article
Interleukin-7 receptor- α gene mutations are not detected in adult T-cell acute lymphoblastic leukemia.
- Published in:
- Cancer Medicine, 2014, v. 3, n. 3, p. 550, doi. 10.1002/cam4.194
- By:
- Publication type:
- Article
Isolated mesenteric CD20-positive myeloid sarcoma.
- Published in:
- 2014
- By:
- Publication type:
- journal article
A prognostic model of therapy-related myelodysplastic syndrome for predicting survival and transformation to acute myeloid leukemia.
- Published in:
- 2014
- By:
- Publication type:
- journal article
CD4(-)/CD8(-) variant of T-cell large granular lymphocytic leukemia or hepatosplenic T-cell lymphoma: a clinicopathologic dilemma.
- Published in:
- 2013
- By:
- Publication type:
- journal article
CD4<sup>-</sup>/CD8<sup>-</sup> Variant of T-Cell Large Granular Lymphocytic Leukemia or Hepatosplenic T-Cell Lymphoma: A Clinicopathologic Dilemma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 5, p. 610, doi. 10.1016/j.clml.2013.04.010
- By:
- Publication type:
- Article
Epstein-Barr Virus-Induced CD30-Positive Diffuse Large B-Cell Lymphoma in a Patient With Mixed-Phenotypic Leukemia Treated With Clofarabine.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 3, p. 342, doi. 10.1016/j.clml.2012.10.002
- By:
- Publication type:
- Article
Azacitidine in Fludarabine-Refractory Chronic Lymphocytic Leukemia: A Phase II Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 3, p. 292, doi. 10.1016/j.clml.2012.11.009
- By:
- Publication type:
- Article
Chronic Lymphocytic Leukemia With Central Nervous System Involvement: A High-Risk Disease?
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 3, p. 338, doi. 10.1016/j.clml.2012.12.007
- By:
- Publication type:
- Article
Ocular Granulocytic Sarcoma: A Case Report and Literature Review of Ocular Extramedullary Acute Myeloid Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 1, p. 93, doi. 10.1016/j.clml.2012.07.008
- By:
- Publication type:
- Article
A Phase II Study of Lenalidomide Alone in Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes With Chromosome 5 Abnormalities.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2012, v. 12, n. 5, p. 341, doi. 10.1016/j.clml.2012.04.001
- By:
- Publication type:
- Article
Phase I-II Study of Bendamustine in Patients With Acute Leukemia and High Risk Myelodysplastic Syndrome.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2012, v. 12, n. 3, p. 197, doi. 10.1016/j.clml.2012.03.004
- By:
- Publication type:
- Article
Primary myelofibrosis marrow-derived CD14<sup>+</sup>/CD34<sup>-</sup> monocytes induce myelofibrosis-like phenotype in immunodeficient mice and give rise to megakaryocytes.
- Published in:
- PLoS ONE, 2019, v. 14, n. 9, p. 1, doi. 10.1371/journal.pone.0222912
- By:
- Publication type:
- Article